| Period Ending: |
LTM
(Last Twelve Months) |
2022 12-31 |
2021 12-31 |
|---|---|---|---|
| Report Filing | 2023-11-13 | 2023-04-04 | 2022-04-01 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Expenses | 2.94 | 2.24 | 0 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | 2.74 | 2.04 | 0 |
| Other Operating Expenses | 0.202 | 0.2 | 0 |
| Operating Income | -2.94 | -2.24 | -0 |
| Net Non-Operating Interest | 0.001 | 0 | 0 |
| Interest Income | 0.001 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Equity & Other Income/(Expense) | 2.73 | 9.41 | 0.008 |
| Income Before Tax | -0.212 | 7.16 | 0.008 |
| Income Tax Expense | 0.677 | 0.402 | 0 |
| Income Attributable to Non-Controlling Interest | 0.001 | -0 | 0 |
| Net Income | -0.89 | 6.76 | 0.008 |
| Depreciation and Amortization | -0.667 | 0.002 | 0 |
| EBITDA | -3.61 | -2.24 | 0 |
| Earnings Per Share (EPS) | -0.191 | 0.38 | 0.001 |
| Diluted Earnings Per Share | -0.206 | 0.38 | 0.001 |
| Weighted Average Shares Outstanding | 10.3 | 17.97 | 6.93 |
| Diluted Weighted Average Shares Outstanding | 10.3 | 17.97 | 6.93 |
